Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple (AAPL) Stock Rockets to Record High on iPhone 17 Hype — What’s Next?

Near-Term Move: Riding the Rally Apple shares have been volatile but are trading very near record levels. On Oct. 20, investors bid the stock up sharply – by the close it was ~$262 (intraday as high as ~$264)ts2.tech. Since then the stock has pulled back a bit to the high-$250s. By the end of Oct. 23, AAPL was around $259.58marketbeat.com (up only a few cents on the week). For context, Apple’s stock is up only a few percent in 2025, far less than peer tech giants (e.g. Nvidia +35%, Microsoft +23% YTDts2.tech). That modest gain reflects Apple’s already lofty valuation. Technically, Apple
24 October 2025
NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

NV Energy Stock Holds Steady Amid Nevada Utility Turmoil

Stock Performance & Trading NV Energy’s stock is essentially flat this week, closing at $23.74 per share on Oct. 24, 2025investing.cominvesting.com. The share price is right at its recent range (previous close $23.74, open $23.71, day’s high $23.75investing.com) and no new 52-week high or low is indicatedinvesting.com. In fact, the investing.com data shows zero price change (0.00%) on the latest quoteinvesting.com. Trading volume is negligible (no fresh trades were reported on Oct. 24), and the 3-month average volume is only about 1.76 million shares per dayinvesting.com. MarketBeat explicitly warns that NVE has been “marked as potentially delisted” and may not
Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Grindr Stock Skyrockets on Buyout Buzz – What Investors Need to Know

Buyout Buzz Sends GRND Soaring Grindr’s stock price skyrocketed after news of a potential insider buyout broke. On Friday, Oct. 24, GRND opened at $14.50 and surged as high as $16.22 intraday, an approximately 25% jump from the prior day’s closeinvesting.com. The rally came after Grindr confirmed that its two largest shareholders – board Chair James Fu Bin Lu and director G. Raymond Zage III – had submitted a preliminary proposal to take the company private at $18.00 per share in cashd18rn0p25nwr6d.cloudfront.netd18rn0p25nwr6d.cloudfront.net. By the end of the day, Grindr stock was hovering around $15.90 (up ~25.6%) on heavy volumebarchart.com, as
Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Clover Health (CLOV) Stock Soars 18% on Analyst Upgrades, Unusual Options Buzz

Stock Performance: Clover Health stock has been exceptionally volatile in mid‑October 2025. On Oct. 21 it jumped ~8.7% intraday to ~$3.20 Marketbeat (from $2.92 prior close), and on Oct. 24 it spiked another ~18%, trading near $3.79 (from $3.20 close on Oct. 23) Reuters. According to Reuters data, that surge propelled CLOV close to its 52-week high (~$4.87) and far above its recent 50‑day moving average (around $2.82) Marketbeat. The 200-day average (~$3.02) was also eclipsed, signaling strong upward momentum Marketbeat. This rally has come on unusually heavy volume (15+ million shares traded on Oct. 24 vs. a 3‑month average
Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Western Union Stock Edges Up on Q3 Beat – CEO Calls Crypto an “Opportunity”

Investors will be watching WU’s short-term outlook as it delivers Q4 results and commentary. Wolfe notes management’s plan to stabilize its core retail business, re-accelerate digital growth, and diversify into new financial servicesinvesting.com. In the near term, stock momentum may hinge on whether retail volumes recover after a 2024 slump, and whether earnings forecasts hold up under higher interest costs. In the long term, Western Union’s global brand, broad agent network and high dividend yield could appeal to conservative investors if the company succeeds in its turnaround. “Our goal is to provide more and better solutions…to give our customers a
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Surges on Cancer Trial Breakthrough – What’s Next?

Theriva’s Stock Swing: In mid-October, Theriva’s Nasdaq-traded shares spiked on news of clinical success. On Oct. 15 the stock jumped from roughly $0.44 to $0.84 intradayts2.tech, an increase of about 92%. This surge coincided with reports that VCN-01 had met the primary endpoints in the VIRAGE Phase 2b trial (see below). The very next trading day, Theriva disclosed a $4.0 million warrant inducement financing. Investors exercising warrants at $0.54 per share provided immediate cashts2.tech, but the announcement also trimmed the earlier stock rally – TOVX settled in the mid-$0.40 range by Oct. 16ts2.techts2.tech. In the days since, the stock has
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet Stock Skyrockets to Record High, Nears $3 Trillion on AI Boom & Earnings Hype

Key Facts – October 24, 2025 Alphabet Rallies to Near Record Highs on AI Momentum Google’s headquarters campus in Mountain View. Alphabet’s stock (GOOG) has been on a tear, reaching all-time highs as investors cheer the company’s AI strides and strong financial performance. Alphabet’s stock is soaring into uncharted territory as of late October 2025. Shares of the Google parent company traded around $260–261 on Friday, flirting with the highest levels in its historystocktwits.com. Earlier this week, Alphabet hit an intraday peak just above $257 – marking a new record – and its latest surge has propelled the company’s market
Comfort Systems (FIX) Stock Skyrockets 17% After Stellar Q3 — What’s Driving the Rally?

Comfort Systems (FIX) Stock Skyrockets 17% After Stellar Q3 — What’s Driving the Rally?

Shares of Comfort Systems USA (NYSE: FIX) exploded on Oct. 24 after the company reported blowout third-quarter results. FIX jumped to about $970 in early trading — up ~17% from the prior close benzinga.com — as investors cheered earnings and backlog far above forecasts. In an official release and conference call, CEO Brian Lane highlighted the “record financial results” and “remarkable quarterly cash flow of over $550 million.” He noted that third-quarter EPS more than doubled last year’s level businesswire.com. Those results handily beat the consensus ($6.20 EPS) and set the stage for the market rally. Comfort Systems’ Q3 financials were indeed eye-popping.
Booz Allen (BAH) Stock Crashes 9% on Weak Q2; Outlook Cut, Analysts Split on Prospects

Booz Allen (BAH) Stock Crashes 9% on Weak Q2; Outlook Cut, Analysts Split on Prospects

Q2 Results and Stock Reaction Booz Allen’s Oct 24, 2025 earnings release shocked investors. Revenue of $2.89 B missed forecasts and fell 8.1% from last year nasdaq.com, while net profit plunged 55%. Adjusted EPS of $1.49 slightly trailed the $1.51 average estimate nasdaq.com. Management blamed a “bifurcated” market – national security projects are healthy, but civil and commercial work is lagging investing.com. In response, the company sharply cut its full-year outlook (FY2026 revenue now ~$11.4 B vs. previously ~$12.3 B) investing.com. Shares fell about 9.4% on the news. In pre-market trading Oct 24 they hit ~$89.75, near the 52-week low investing.com. By market
MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI (NASDAQ: MSAI) – Shares skyrocketed in late October 2025 and then plunged, reflecting news-driven swings. On Oct. 23 the stock jumped (roughly +42–100%) after the company announced a major U.S. deployment deal ts2.tech. By Oct. 24 it fell nearly 50% when MSAI revealed a $14 million private share placement at $0.409 per share newsfilecorp.com reuters.com. As of Oct. 24 midday, MSAI trades near $0.73 reuters.com (down ~47% on the day and about 32% below its price a year ago tipranks.com). Key fundamentals are modest: full-year 2024 revenue was $7.4 M (2023: $5.4 M) with a net loss of $21.5 M ts2.tech. Q2
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Key Facts: – Neuphoria (Nasdaq: NEUP) shares plunged ~67% in after-hours trading on Oct 20 when its lead drug BNC210 failed a Phase 3 SAD trial Investing. The AFFIRM-1 trial missed both primary and secondary endpoints, and the company immediately halted its social anxiety program and launched a full strategic review Investing Globenewswire. – CEO Spyros Papapetropoulos vowed to “conserve our cash position” while exploring options to “maximize value for shareholders” Globenewswire. Neuphoria will evaluate BNC210 in PTSD (where earlier data were promising) and otherwise cut spending. – NEUP stock fell from about $15.40 on Oct 20 to roughly $5

Stock Market Today

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

7 February 2026
AST SpaceMobile shares jumped 9.1% to $101.79 Friday after a volatile week, with 15.9 million shares traded. AT&T said it will use Amazon Leo’s satellite network to reach business customers outside its terrestrial footprint but stated this will not affect its partnership with AST. A new 2x short ETF tied to ASTS, ticker ASTN, began trading on Cboe. AST’s next “BlueBird 7” satellite launch is set for late February on Blue Origin’s New Glenn.
Go toTop